Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             92 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs Quan, Fu Shi
2008
26 Supplement 6 p. 3352-3361
10 p.
artikel
2 Abortive reaction and time of scar formation after BCG vaccination Faridi, M.M.A.
2008
26 Supplement 6 p. 289-290
2 p.
artikel
3 A meta-analysis of human papillomavirus type-distribution in women from South Asia: Implications for vaccination Bhatla, Neerja
2008
26 Supplement 6 p. 2811-2817
7 p.
artikel
4 Amount of maternal rotavirus-specific antibodies influence the outcome of rotavirus vaccination of newborn mice with virus-like particles Johansson, E.
2008
26 Supplement 6 p. 778-785
8 p.
artikel
5 A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Côte d’Ivoire Ekra, Daniel
2008
26 Supplement 6 p. 2753-2761
9 p.
artikel
6 An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results Schiller, John T.
2008
26 Supplement 6 p. K53-K61
nvt p.
artikel
7 A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization Shiota, Seiji
2008
26 Supplement 6 p. 6441-6444
4 p.
artikel
8 A recombinant pseudorabies virus expressing rabies virus glycoprotein: Safety and immunogenicity in dogs Yuan, Ziguo
2008
26 Supplement 6 p. 1314-1321
8 p.
artikel
9 Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: Preliminary results Dhiman, Neelam
2008
26 Supplement 6 p. 1731-1736
6 p.
artikel
10 Bath vaccination of rainbow trout (Oncorhynchus mykiss Walbaum) against Yersinia ruckeri: Effects of temperature on protection and gene expression Raida, M.K.
2008
26 Supplement 6 p. 1050-1062
13 p.
artikel
11 Burden and Trends of Type-specific Human Papillomavirus Infections and Related diseases in the Asia Pacific Region Parkin, D. Maxwell
2008
26 Supplement 6 p. M1-M16
nvt p.
artikel
12 Comparison between two severity scoring scales commonly used in the evaluation of rotavirus gastroenteritis in children Givon-Lavi, Noga
2008
26 Supplement 6 p. 5798-5801
4 p.
artikel
13 Comparison of α-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients Trepiakas, Redas
2008
26 Supplement 6 p. 2824-2832
9 p.
artikel
14 Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073 Fytili, P.
2008
26 Supplement 6 p. 3818-3826
9 p.
artikel
15 Development and optimisation of a procedure for the production of Parapoxvirus ovis by large-scale microcarrier cell culture in a non-animal, non-human and non-plant-derived medium Pohlscheidt, M.
2008
26 Supplement 6 p. 1552-1565
14 p.
artikel
16 Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination Rieber, Nikolaus
2008
26 Supplement 6 p. 6929-6935
7 p.
artikel
17 Dynamics of acute and memory mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes Srivastava, Indresh
2008
26 Supplement 6 p. 2796-2806
11 p.
artikel
18 Editorial Board 2008
26 Supplement 6 p. CO2-
1 p.
artikel
19 Editorial Board 2008
26 Supplement 6 p. CO2-
1 p.
artikel
20 Editorial Board 2008
26 Supplement 6 p. CO2-
1 p.
artikel
21 Editorial Board 2008
26 Supplement 6 p. CO2-
1 p.
artikel
22 Editorial Board 2008
26 Supplement 6 p. CO2-
1 p.
artikel
23 Editorial Board/Aims and Scope 2008
26 Supplement 6 p. CO2-
1 p.
artikel
24 Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway Vestrheim, Didrik F.
2008
26 Supplement 6 p. 3277-3281
5 p.
artikel
25 Epidemiology of Human Papillomavirus Infection in Men, Cancers other than Cervical and Benign Conditions Giuliano, Anna R.
2008
26 Supplement 6 p. K17-K28
nvt p.
artikel
26 Estimating the impact of childhood influenza vaccination programmes in England and Wales Vynnycky, Emilia
2008
26 Supplement 6 p. 5321-5330
10 p.
artikel
27 Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys Nigatu, Wondatir
2008
26 Supplement 6 p. 4769-4774
6 p.
artikel
28 Evaluation of the effects of human leukocyte IFN-α on the immune response to the HBV vaccine in healthy unvaccinated individuals Rizza, Paola
2008
26 Supplement 6 p. 1038-1049
12 p.
artikel
29 Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers Wright, Peter F.
2008
26 Supplement 6 p. 882-890
9 p.
artikel
30 Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals von Teichman, Beate F.
2008
26 Supplement 6 p. 5014-5021
8 p.
artikel
31 Evaluation of widely consumed botanicals as immunological adjuvants Ragupathi, Govind
2008
26 Supplement 6 p. 4860-4865
6 p.
artikel
32 Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses Du, Ning
2008
26 Supplement 6 p. 2912-2918
7 p.
artikel
33 HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine Joura, Elmar A.
2008
26 Supplement 6 p. 6844-6851
8 p.
artikel
34 Identification of immunogenic HLA-B7 “Achilles’ heel” epitopes within highly conserved regions of HIV De Groot, Anne S.
2008
26 Supplement 6 p. 3059-3071
13 p.
artikel
35 Immunogenicity and protective efficacy of a tuberculosis DNA vaccine co-expressing pro-apoptotic caspase-3 Gartner, Tatiana
2008
26 Supplement 6 p. 1458-1470
13 p.
artikel
36 Immunogenicity and reactogenicity of a trivalent influenza split vaccine in previously unvaccinated children aged 6–9 and 10–13 years Schmidt-Ott, Ruprecht
2007
26 Supplement 6 p. 32-40
9 p.
artikel
37 Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth Carniel, E.F.
2008
26 Supplement 6 p. 647-652
6 p.
artikel
38 Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive®): A double-blind, randomized and controlled trial Jiang, Wei-Ping
2008
26 Supplement 6 p. 2297-2301
5 p.
artikel
39 Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia Saaka, M.
2008
26 Supplement 6 p. 3719-3726
8 p.
artikel
40 Immunogenicity for 16 serotypes of a unique schedule of pneumococcal vaccines in a high-risk population Leach, Amanda J.
2008
26 Supplement 6 p. 3885-3891
7 p.
artikel
41 Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa–IPV–HBV–Hib combination vaccine in healthy infants Olivier, C.
2008
26 Supplement 6 p. 3142-3152
11 p.
artikel
42 Immunogenic properties of plant-derived recombinant smallpox vaccine candidate pB5 Portocarrero, Carla
2008
26 Supplement 6 p. 5535-5540
6 p.
artikel
43 Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis West, Nicholas P.
2008
26 Supplement 6 p. 3853-3859
7 p.
artikel
44 Impact of prior immunological exposure on vaccine delivery by Salmonella enterica serovar Typhimurium Gahan, Michelle E.
2008
26 Supplement 6 p. 6212-6220
9 p.
artikel
45 Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination Sugimura, Tetsu
2008
26 Supplement 6 p. 2700-2705
6 p.
artikel
46 Inactivated influenza vaccine (IIV) in children <2 years of age: Examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine McMahon, A.W.
2008
26 Supplement 6 p. 427-429
3 p.
artikel
47 Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants Hu, Yali
2008
26 Supplement 6 p. 6064-6067
4 p.
artikel
48 Influenza vaccine effectiveness and confounding factors among young children Fujieda, Megumi
2008
26 Supplement 6 p. 6481-6485
5 p.
artikel
49 Introduction of Human Papillomavirus Vaccines into Developing Countries - International Strategies for Funding and Procurement Andrus, Jon Kim
2008
26 Supplement 6 p. K87-K92
nvt p.
artikel
50 Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990–2003 Asatryan, Armenak
2008
26 Supplement 6 p. 1166-1172
7 p.
artikel
51 Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya Agak, George W.
2008
26 Supplement 6 p. 1963-1971
9 p.
artikel
52 Long-term antibody persistence in children primed and boosted with a DTPw-HBV vaccine at 2, 4, 6, 18, months of age Poovorawan, Yong
2008
26 Supplement 6 p. 1535-1540
6 p.
artikel
53 Long-term antibody persistence induced by a combined hepatitis A and B vaccine in children and adolescents Diaz-Mitoma, Francisco
2008
26 Supplement 6 p. 1759-1763
5 p.
artikel
54 Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Schuller, E.
2008
26 Supplement 6 p. 4382-4386
5 p.
artikel
55 Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunization Gudmundsdotter, Lindvi
2008
26 Supplement 6 p. 5107-5110
4 p.
artikel
56 MeNZB™ vaccine and epidemic control: When do you stop vaccinating? Loring, Belinda J.
2008
26 Supplement 6 p. 5899-5904
6 p.
artikel
57 Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates Fine, Donald L.
2008
26 Supplement 6 p. 3497-3506
10 p.
artikel
58 Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A Taylor, Claribel P.
2008
26 Supplement 6 p. 3404-3409
6 p.
artikel
59 Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies Zhang, Shoufeng
2008
26 Supplement 6 p. 345-350
6 p.
artikel
60 Outer membrane vesicles as acellular vaccine against pertussis Roberts, Roy
2008
26 Supplement 6 p. 4639-4646
8 p.
artikel
61 Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries Cuzick, Jack
2008
26 Supplement 6 p. K29-K41
nvt p.
artikel
62 Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults Nolan, Terry M.
2008
26 Supplement 6 p. 4160-4167
8 p.
artikel
63 Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis Katoch, K.
2008
26 Supplement 6 p. 1228-1234
7 p.
artikel
64 Preclinical assessment of the receptor-binding domain of Plasmodium vivax Duffy-binding protein as a vaccine candidate in rhesus macaques Moreno, A.
2008
26 Supplement 6 p. 4338-4344
7 p.
artikel
65 Prophylactic HPV vaccines: New interventions for cancer control Barr, Eliav
2008
26 Supplement 6 p. 6244-6257
14 p.
artikel
66 Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use Fasanella, A.
2008
26 Supplement 6 p. 5684-5688
5 p.
artikel
67 Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice Qu, Daofeng
2008
26 Supplement 6 p. 4541-4548
8 p.
artikel
68 Protective effects of recombinant staphylococcal enterotoxin type C mutant vaccine against experimental bovine infection by a strain of Staphylococcus aureus isolated from subclinical mastitis in dairy cattle Chang, Byoung Sun
2008
26 Supplement 6 p. 2081-2091
11 p.
artikel
69 Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser) Jarvi, Susan I.
2008
26 Supplement 6 p. 5338-5344
7 p.
artikel
70 Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands David, Silke
2008
26 Supplement 6 p. 5883-5887
5 p.
artikel
71 Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice Xu, Juan
2008
26 Supplement 6 p. 4519-4525
7 p.
artikel
72 Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5–14 years old children Esteghamati, Abdoulreza
2008
26 Supplement 6 p. 5058-5061
4 p.
artikel
73 Role of different genes in the CS6 operon for surface expression of Enterotoxigenic Escherichia coli colonization factor CS6 Tobias, Joshua
2008
26 Supplement 6 p. 5373-5380
8 p.
artikel
74 Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations Adam, D.
2008
26 Supplement 6 p. 5944-5951
8 p.
artikel
75 Safety and efficacy of live attenuated influenza vaccine in children 2–7 years of age Belshe, Robert B.
2008
26 Supplement 6 p. D10-D16
nvt p.
artikel
76 Safety and immunogenicity of a DTaP-IPVVero (serum-free) combination vaccine in comparison to DTaP-IPVMkc when administered simultaneously with Haemophilus influenzae type b conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age Pietrzyk, Jacek J.
2008
26 Supplement 6 p. 5296-5303
8 p.
artikel
77 Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children Nolan, Terry
2008
26 Supplement 6 p. 6383-6391
9 p.
artikel
78 Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines Wheeler, Cosette M.
2008
26 Supplement 6 p. 686-696
11 p.
artikel
79 Safety and immunogenicity of CRM197-conjugated pneumococcal–meningococcal C combination vaccine (9vPnC–MnCC) whether given in two or three primary doses Sigurdardottir, Sigurveig Th.
2008
26 Supplement 6 p. 4178-4186
9 p.
artikel
80 Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults Gorse, Geoffrey J.
2008
26 Supplement 6 p. 215-223
9 p.
artikel
81 Safety evaluation of a canine hepatitis DNA vaccine Liu, Fu Ying
2008
26 Supplement 6 p. 6925-6928
4 p.
artikel
82 Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnel Singer, Darrell E.
2008
26 Supplement 6 p. 869-873
5 p.
artikel
83 Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age Block, Stan L.
2008
26 Supplement 6 p. 4940-4946
7 p.
artikel
84 Supplementation of whole-cell pertussis vaccines with lipopolysaccharide analogs: Modification of vaccine-induced immune responses Geurtsen, Jeroen
2008
26 Supplement 6 p. 899-906
8 p.
artikel
85 The cost-effectiveness of typhoid Vi vaccination programs: Calculations for four urban sites in four Asian countries Cook, Joseph
2008
26 Supplement 6 p. 6305-6316
12 p.
artikel
86 The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis Araujo, Zaida
2008
26 Supplement 6 p. 5575-5581
7 p.
artikel
87 The effect of oral administration of a homologous hilA mutant strain on the long-term colonization and transmission of Salmonella Enteritidis in broiler chickens Bohez, Lotte
2008
26 Supplement 6 p. 372-378
7 p.
artikel
88 The effects of IL-6 and TNF-α as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination Su, Baowei
2008
26 Supplement 6 p. 5111-5122
12 p.
artikel
89 Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma Toomey, Deirdre
2008
26 Supplement 6 p. 3540-3549
10 p.
artikel
90 The risk of simple febrile seizures after immunisation with a new group B meningococcal vaccine, New Zealand Stehr-Green, Paul
2008
26 Supplement 6 p. 739-742
4 p.
artikel
91 Vaccination and the evolutionary ecology of human papillomavirus Poolman, Eric M.
2008
26 Supplement 6 p. C25-C30
nvt p.
artikel
92 Vitamin A supplements are well tolerated with the pentavalent vaccine Newton, Sam
2008
26 Supplement 6 p. 6608-6613
6 p.
artikel
                             92 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland